115 related articles for article (PubMed ID: 23207768)
1. Effects of clioquinol analogues on the hypoxia-inducible factor pathway and intracelullar mobilization of metal ions.
Kim SY; Lee MJ; Kim JW; Na YR; Lee HY; Cho H; Lee KB; Lee YM; Lee C; Park H; Yang EG
Biol Pharm Bull; 2012; 35(12):2160-9. PubMed ID: 23207768
[TBL] [Abstract][Full Text] [Related]
2. Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells.
Choi SM; Choi KO; Park YK; Cho H; Yang EG; Park H
J Biol Chem; 2006 Nov; 281(45):34056-63. PubMed ID: 16973622
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.
Tian YM; Yeoh KK; Lee MK; Eriksson T; Kessler BM; Kramer HB; Edelmann MJ; Willam C; Pugh CW; Schofield CJ; Ratcliffe PJ
J Biol Chem; 2011 Apr; 286(15):13041-51. PubMed ID: 21335549
[TBL] [Abstract][Full Text] [Related]
4. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
5. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes.
Li Q; Chen H; Huang X; Costa M
Toxicol Appl Pharmacol; 2006 Jun; 213(3):245-55. PubMed ID: 16386771
[TBL] [Abstract][Full Text] [Related]
6. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
7. The zinc chelator, N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1alpha protein in normoxic cells.
Choi SM; Choi KO; Lee N; Oh M; Park H
Biochem Biophys Res Commun; 2006 May; 343(4):1002-8. PubMed ID: 16579968
[TBL] [Abstract][Full Text] [Related]
8. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
9. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
12. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
13. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
14. Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy.
Hofer T; Desbaillets I; Höpfl G; Gassmann M; Wenger RH
FASEB J; 2001 Dec; 15(14):2715-7. PubMed ID: 11606485
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron.
Park SS; Bae I; Lee YJ
J Cell Biochem; 2008 Apr; 103(6):1989-98. PubMed ID: 17973296
[TBL] [Abstract][Full Text] [Related]
16. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
Seo K; Seo S; Ki SH; Shin SM
Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
19. The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
Linden T; Katschinski DM; Eckhardt K; Scheid A; Pagel H; Wenger RH
FASEB J; 2003 Apr; 17(6):761-3. PubMed ID: 12594177
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.
Demidenko ZN; Rapisarda A; Garayoa M; Giannakakou P; Melillo G; Blagosklonny MV
Oncogene; 2005 Jul; 24(30):4829-38. PubMed ID: 15897903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
